Diagnostic and Prognostic Value of Metastasis Inducer S100A4 Transcripts in Plasma of Colon, Rectal, and Gastric Cancer Patients

Christofori, 2006, New signals from the invasive front, Nature, 441, 444, 10.1038/nature04872 Stein, 2007, Clinical, biological, and molecular aspects of metastasis in colorectal cancer, Recent Res Cancer Res, 176, 61, 10.1007/978-3-540-46091-6_7 Beahrs, 1992, Staging of cancer of the colon and rectum, Cancer, 70, 1393, 10.1002/1097-0142(19920901)70:3+<1393::AID-CNCR2820701530>3.0.CO;2-P Hayashi, 2000, Superiority of a new UICC-TNM staging system for gastric carcinoma, Surgery, 127, 129, 10.1067/msy.2000.102171 Anker, 2003, Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?, Int J Cancer, 103, 149, 10.1002/ijc.10791 El-Hefnawy, 2004, Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics, Clin Chem, 50, 564, 10.1373/clinchem.2003.028506 Goebel, 2005, Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias, Dis Markers, 21, 105, 10.1155/2005/218759 Fleischhacker, 2007, Circulating nucleic acids (CNAs) and cancer–a survey, Biochim Biophys Acta, 1775, 181 Swarup, 2007, Circulating (cell-free) nucleic acids—a promising, non-invasive tool for early detection of several human diseases, FEBS Lett, 581, 795, 10.1016/j.febslet.2007.01.051 García, 2008, Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched, RNA, 14, 1424, 10.1261/rna.755908 Mazzucchelli, 2002, Protein S100A4: too long overlooked by Pathologists?, Am J Pathol, 160, 7, 10.1016/S0002-9440(10)64342-8 Boye, 2010, S100A4 and metastasis: a small actor playing many roles, Am J Pathol, 176, 528, 10.2353/ajpath.2010.090526 Takenaga, 1994, Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin, J Cell Biol, 124, 757, 10.1083/jcb.124.5.757 Chen, 2001, Binding to intracellular targets of the metastasis-inducing protein, S100A4 (p9Ka) Biochem Biophys Res Commun, 286, 1212, 10.1006/bbrc.2001.5517 Li, 2006, The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA, Cancer Res, 66, 5173, 10.1158/0008-5472.CAN-05-3087 Kriajevska, 2002, Liprin beta 1, a member of the family of LAR transmembrane tyrosine phosphatase-interacting proteins, is a new target for the metastasis-associated protein S100A4 (Mts1), J Biol Chem, 277, 5229, 10.1074/jbc.M110976200 Grigorian, 2001, Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 Protein, J Biol Chem, 276, 22699, 10.1074/jbc.M010231200 Schmidt-Hansen, 2004, Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity, Oncogene, 23, 5487, 10.1038/sj.onc.1207720 Semov, 2005, Metastasis-associated protein S100A4 induces angiogenesis through interaction with annexin II and accelerated plasmin formation, J Biol Chem, 280, 20833, 10.1074/jbc.M412653200 Helfman, 2005, The metastasis associated protein S100A4: role in tumour progression and metastasis, Br J Cancer, 92, 1955, 10.1038/sj.bjc.6602613 Garrett, 2006, S100A4, a mediator of metastasis, J Biol Chem, 281, 677, 10.1074/jbc.R500017200 Tarabykina, 2007, Metastasis-associated protein S100A4: spotlight on its role in cell migration, Curr Cancer Drug Targets, 7, 217, 10.2174/156800907780618329 Sherbet, 2009, Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy, Cancer Lett, 280, 15, 10.1016/j.canlet.2008.10.037 Takenaga, 1997, Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas, Clinical Cancer Res, 3, 2309 Gongoll, 2002, Prognostic significance of calcium-binding protein S100A4 in colorectal cancer, Gastroenterology, 123, 1478, 10.1053/gast.2002.36606 Flatmark, 2003, Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer, J Pathol, 200, 589, 10.1002/path.1381 Cho, 2005, Overexpression of S100A4 is closely associated with progression of colorectal cancer, World J Gastroenterol, 11, 4852, 10.3748/wjg.v11.i31.4852 Hemandas, 2006, Metastasis-associated protein S100A4—a potential prognostic marker for colorectal cancer, J Surg Oncol, 93, 498, 10.1002/jso.20460 Stein, 2006, The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer, Gastroenterology, 131, 1486, 10.1053/j.gastro.2006.08.041 Kim, 2009, Enhanced S100A4 protein expression is clinicopathologically significant to metastatic potential and p53 dysfunction in colorectal cancer, Oncol Rep, 22, 41, 10.3892/or_00000404 Yonemura, 2000, Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer, Clinical Cancer Res, 6, 4234 Kim, 2008, Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer, Cancer Invest, 26, 152, 10.1080/07357900701518909 Yoon, 2008, Expression of S100A4, E-cadherin, alpha- and beta-catenin in gastric adenocarcinoma Hepatogastroenterology, 55, 1916 Li, 2008, Frequent S100A4 expression with unique splicing pattern in gastric cancers: a hypomethylation event paralleled with E-cadherin reduction and Wnt activation, Transl Oncol, 1, 165, 10.1593/tlo.08148 Heizmann, 2007, Pathologies involving the S100 proteins and RAGE, Subcell Biochem, 45, 93, 10.1007/978-1-4020-6191-2_5 Grigorian, 2008, Metastasis-inducing S100A4 protein: implication in non-malignant human pathologies, Curr Mol Med, 8, 492, 10.2174/156652408785747942 Oslejsková, 2008, The metastasis associated protein S100A4: a potential novel link to inflammation and consequent aggressive behaviour of rheumatoid arthritis synovial fibroblasts, Ann Rheum Dis, 67, 1499, 10.1136/ard.2007.079905 Fleischhacker, 2001, Detection of amplifiable messenger RNA in the serum of patients with lung cancer, Ann NY Acad Sci, 945, 179, 10.1111/j.1749-6632.2001.tb03883.x Dheda, 2004, Validation of housekeeping genes for normalizing RNA expression in real-time PCR, Biotechniques, 37, 112, 10.2144/04371RR03 Bustin, 2002, Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems, J Mol Endocrinol, 29, 23, 10.1677/jme.0.0290023 Holm, 1979, A simple sequentially rejective multiple test procedure, Scand J Statistics, 6, 65 El-Abd, 2008, Serum metastasin mRNA is an important survival predictor in breast cancer, Br J Biomed Sci, 65, 90, 10.1080/09674845.2008.11732804 Flatmark, 2004, Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum, Tumour Biol, 25, 31, 10.1159/000077721 Peng, 2009, Pulmonary Vascular Complications of Liver Disease Study Group: plasma levels of S100A4 in portopulmonary hypertension, Biomarkers, 14, 156, 10.1080/13547500902773896 Taylor, 2002, S100A4 (p9Ka) protein in colon carcinoma and liver metastases: association with carcinoma cells and T-lymphocytes, Br J Cancer, 86, 409, 10.1038/sj.bjc.6600071 Hernan, 2003, ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma, Cancer Res, 63, 140 Chen, 2009, Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin, J Biol Chem, 284, 1484, 10.1074/jbc.M803997200 Cruz-Monserrate, 2007, Upregulation and redistribution of integrin alpha6beta4 expression occurs at an early stage in pancreatic adenocarcinoma progression, Mod Pathol, 20, 656, 10.1038/modpathol.3800782 Bernards, 2002, A progression puzzle, Nature, 418, 823, 10.1038/418823a Van't Veer, 2003, Road map to metastasis, Nat Med, 9, 999, 10.1038/nm0803-999b Fritzmann, 2009, A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential, Gastroenterology, 137, 165, 10.1053/j.gastro.2009.03.041 Puppa, 2010, TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues, Arch Pathol Lab Med, 134, 837, 10.5858/134.6.837 Wu, 2007, Elevated plasma osteopontin associated with gastric cancer development, invasion and survival, Gut, 56, 782, 10.1136/gut.2006.109868 Tani, 2007, Circulating cell-free mRNA in plasma as a tumor marker for patients with primari and recurrent gastric cancer, Anticancer Res, 27, 1207 Lledo, 2004, Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer, Colorectal Dis, 6, 236, 10.1111/j.1463-1318.2004.00627.x Silva, 2002, Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells, Gut, 50, 530, 10.1136/gut.50.4.530 Goldstein, 2005, Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer, Cancer Invest, 23, 338, 10.1081/CNV-58878 Garcia, 2006, Thymidylate synthase messenger RNA expression in plasma from patients with colon cancer: prognostic potential, Clinical Cancer Res, 12, 2095, 10.1158/1078-0432.CCR-05-1644 Wang, 2007, Multiple molecular markers as predictors of colorectal cancer in patients with normal perioperative serum carcinoembryonic antigen levels, Clinical Cancer Res, 13, 2406, 10.1158/1078-0432.CCR-06-2054 Garcia, 2007, Prognostic value of LISCH7 mRNA in plasma and tumor of colon cancer patients, Clinical Cancer Res, 13, 6351, 10.1158/1078-0432.CCR-07-0882 Wong, 2004, Quantification of plasma beta-catenin mRNA in colorectal cancer and adenoma patients, Clinical Cancer Res, 10, 1613, 10.1158/1078-0432.CCR-1168-3 Sack, 2009, Wnt up your mind—intervention strategies for S100A4-induced metastasis in colon cancer, Gen Physiol Biophys, 28, F55 Kim, 2009, Identification of S100A8 and S100A9 as serological markers for colorectal cancer, J Proteome Res, 8, 1368, 10.1021/pr8007573